BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 3, 2020
View Archived Issues
Protagonist and Janssen select new oral peptide IL-23 receptor antagonist candidates
Read More
Updated preclinical data presented for psychedelic molecule FT-104
Read More
FDA clears IND application for phase I study of CORVax12 vaccine candidate for COVID-19
Read More
Promising topline data presented from phase II study of BPN-14770 in fragile X syndrome
Read More
Enanta Pharmaceuticals divulges new antivirals
Read More
Rottapharm Biotech discloses new DDR2 inhibitors
Read More
Peloton Therapeutics identifies RBM39 degradation inducers
Read More
Sichuan Kelun-Biotech Biopharmaceutical synthesizes USP7 inhibitors
Read More
Azitra discovers recombinant microorganisms for treating atopic dermatitis
Read More
Ester prodrug of a mGlu2/3 receptor agonist shows improved oral bioavailability
Read More
Second-generation anti-HCV cyclophilin inhibitor with reduced immunosuppressive activity
Read More
FDA approves IND for phase I study of PD1-Vaxx in NSCLC
Read More
A novel inducer of fetal hemoglobin with improved PK and PD properties
Read More
Results from SPI2 trial do not support the use of high-dose biotin for treating progressive MS
Read More
Insights, strategies for stabilizing dystrophin
Read More
Angiotensin 1-7 as novel biomarker to detect transplant AKI in children
Read More
Epigenomics approach links neurodegeneration SNPs to genes, cells, mechanisms
Read More
First-in-class LDHA inhibitor CHK-336 for treating primary hyperoxaluria
Read More
dEF-3122 improves inflammation and fibrosis in liver and kidneys of NASH mice
Read More
PLVAP, a new biomarker for endothelial injury in diabetic nephropathy
Read More
E.U. approval for Tecentriq with Avastin for advanced or unresectable HCC
Read More
FDA clears initiation of phase III trial of itolizumab in COVID-19 patients with ARDS
Read More
Preclinical data presented for the PSMA analogue [47Sc]Sc-PSMA-D4
Read More
Senhwa submits IND for phase II trial of silmitasertib for severe COVID-19
Read More
FDA lifts clinical hold on Poseida's phase I study of P-PSMA-101 in metastatic CRPC
Read More
Neuraly receives IND clearance for phase IIb study of NLY-01 in Alzheimer's disease
Read More
CureVac reports interim phase I data with SARS-CoV-2 vaccine candidate CVnCoV
Read More
Regeneron pauses dosing in phase II trial of garetosmab for fibrodysplasia ossificans progressiva
Read More